Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A MaassenVanDenBrink
A Human Trigeminovascular Biomarker for Antimigraine Drugs: A Randomised, Double-Blind, Placebo-Controlled, Crossover Trial With Sumatriptan
Cephalalgia
Medicine
Neurology
Related publications
Bumetanide in Hypokalaemic Periodic Paralysis: A Randomised, Double-Blind, Placebo Controlled Phase II Clinical Trial With a Crossover Design
Neuromuscular Disorders
Child Health
Neurology
Pediatrics
Perinatology
Genetics
Donepezil for Dementia in Parkinson's Disease: A Randomised, Double Blind, Placebo Controlled, Crossover Study
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
Zileuton for Pruritus in Sjögren-Larsson Syndrome: A Randomized Double-Blind Placebo-Controlled Crossover Trial
Acta Dermato-Venereologica
Dermatology
Medicine
Photodynamic Therapy for Dysplastic Barrett's Oesophagus: A Prospective, Double Blind, Randomised, Placebo Controlled Trial
Gut
Gastroenterology
CCR5 Blockade in Rheumatoid Arthritis: A Randomised, Double-Blind, Placebo-Controlled Clinical Trial
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Randomised, Double-Blind, Placebo-Controlled Trial of EPs 7630 in Adults With COPD
Respiratory Medicine
Pulmonary
Respiratory Medicine
Clemastine Fumarate as a Remyelinating Therapy for Multiple Sclerosis (ReBUILD): A Randomised, Controlled, Double-Blind, Crossover Trial
The Lancet
Medicine
Dietary Fructo-Oligosaccharides in Healthy Adults Do Not Negatively Affect Faecal Cytotoxicity: A Randomised, Double-Blind, Placebo-Controlled Crossover Trial
British Journal of Nutrition
Medicine
Nutrition
Dietetics
Pazopanib for Metastatic Soft-Tissue Sarcoma (PALETTE): A Randomised, Double-Blind, Placebo-Controlled Phase 3 Trial
The Lancet
Medicine
